Recent advances in our knowledge of the biochemistry, pharmacology, and cell biology of ligand-induced, stimulated turnover of inositol lipids in such diverse tissues as insect salivary glands, platelets, lymphocytes, and a number of exocrine glands have greatly altered our understanding of intracellular events leading to secretion, contraction, chemotaxis, and other cellular responses. Much of what has been learned regarding ligand-stimulated turnover of inosito1 lipids has come from nonneural systems, so that the presumption that signal transduction via this mechanism mediates significant steps in neural function must still be considered inferential. This reservation has been a major theme of a recent comprehensive review (Hawthorne, 1986) . Nevertheless, that the brain contains large amounts of the substrates and enzymes of inositol lipid turnover and its associated second messenger systems and, further, that it is enriched with receptors that are linked to stimulated inositol lipid turnover argue strongly that the phosphoinositides indeed play an important role in brain function. There exist several general reviews on stimulated inositol lipid turnover (Bemidge, 1984; Bemdge and Irvine, 1984; Nishizuka, 1984 Nishizuka, , 1986 Hokin, 1985; Abdel-Latif, 1986; Downes, 1986; Williamson, 1986) , including several that emphasize the nervous system (Downes, 1982 (Downes, , 1983 Fisher and Agranoff, 1986; Hawthorne, 1986; Nahorski et al., 1986). The present contribution emphasizes developments of neurochemical relevance since a review on the subject in this journal 8 years ago (Hawthorne and Pickard, 1979).
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CHEMISTRY AND ENZYMOLOGY OF INOSITOL LIPIDS AND INOSITOL PHOSPHATES
The inositol lipids Phosphatidylinositol (PI), depicted in Fig. lA , is a glycerophospholipid in which the sn-1 and sn-2 positions of glycerol are esterified to fatty acids, whereas the sn-3 position is phosphodiesterified to the 1)-1 position of myo-inositol. myo-Inositol is one of nine possible isomers of hexahydroxycyclohexane, which, in its preferred chair conformation, has one axial and five equatorial hydroxyl groups. The molecule can be likened to a turtle (Fig. 1B ) in which the four legs and tail are the five equatorial hydroxyls, numbered counterclockwise from above, starting with the right foreleg as position D-1 (Fig. 1 C) . The turtle's head is thus the axial hydroxyl at position D-2. The phosplhatidyl group in all of the phosphoinositides is linked to D-1 (the right foreleg).
PI is synthesized in brain from a liponucleoiide intermediate, cytidine diphosphodiacylglycerol (CDP-DG) (Agranoff et al., 1958) , and inositol in the pres- ence of a transferase (Benjamins and Agranoff, 1969) and can then be phosphorylated via PI kinase and ATP to form phosphatidylinositol4-phosphate (PIP) (Colodzin and Kennedy, 1965; Kai et al., 1966) . This product may be further phosphorylated via PIP kinase and ATP to form phosphatidylinositol 4,5-bisphosphate (PIP2) (Kai et al., 1968) . It had been shown by Hokin and Hokin (1 955) , in studies in which intact cell preparations were incubated in the presence of muscarinic ligands, that the labeling of two quantitatively minor lipids, phosphatidate (PA) and PI, was enhanced. It was suggested that the ligand stimulated the phosphodiesteratic cleavage of PI (Hokin and Hokin, 1964) to yield diacylglycerol (DG), which could then be converted to PA by DG kinase (Hokin and Hokin, 1959) and, thence, via de novo synthesis Agranoff, 1965, 1967; Carter and Kennedy, 1966) to PI. Phosphodiesterolysis of PI via a phospholipase C-type cleavage (Dawson, 1959; Kemp et al., 1959) was then proposed to complete a cycle (Fig. 2a) . It has become increasingly clear in the last few years that the initial ligand-stimulated step is the stimulated breakdown of PIP2 rather than that of PI (Fig. 2b) , with the concomitant formation of DG and inositol 1,4,5-trisphosphate ( 1,4,5-IP3) (Akhtar and Abdel-Latif, 1980; Agranoff et al., 1983; Berridge et al., 1983) . The two products of this phosphodiesteratic cleavage are now known to have separate second messenger properties: DG stimulates protein kinase C (PK-C), a Ca2+-activated protein kinase (Nishizuka, 1984) , whereas IP3 mobilizes Ca2+ from intracellular stores (Berridge and . The brain is particularly enriched in PK-C (Hirasawa and Nishizuka, 1985) , and several brain-specific proteins have been shown to be selectively phosphorylated via this kinase (Nishizuka, 1986) . In platelet membranes, the three inositol phospholipids, PI, PIP, and PIP2, all appear to be cleaved by a common phosphodiesterase in the presence of Ca2+ (Wilson et al., 1984) , although when Ca" is reduced by EGTA chelation, only PIP and PIP2 are hydrolyzed. In brain membranes, Ca" is required for phospholipase C cleavage of PIP and PIP, (Van Rooijen et al., 1983) . Although there is evidence that the initial cleavage stimulated by ligand is at the level of polyphosphoinositides, at later times the resultant elevated intracellular Ca" levels could then lead to further phosphodiesteratic breakdown of PI (Wilson et al., 198%). Because the brain, like other tissues, contains much more PI than PIP or PIP2, PI is potentially a more plentiful source of DG for activation of cDTG PI FIG. 2 . Stimulated turnover of inositol lipids in response to ligand receptor activation. An earlier view of the cycle considered PI breakdown to DG to be stimulated (a) . Evidence in the last few years indicates that the stimulated breakdown occurs at the level of PIPp (b) (from Fisher and Agranoff, 1986) .
PK-C. It should be noted that lipid metabolism outside the phosphoinositide cycle can both produce and consume DG (see Daniel et al., 1986; Snider et al., 1987) .
The Ca2' sensitivity of stimulated phosphoinositide turnover in the CNS represents a major characteristic of neural tissues. Omission of Ca2+ from the incubation medium can attenuate, and inclusion of Ca2+ chelators can abolish, stimulated inositol lipid turnover in brain (Griffin et al., 1979; Fisher and Agranoff, 1980, 1981; Gonzales and Crews, 1984; Pearce et al., 1985) . Moreover, in some circumstances, addition of the divalent cationophore A23187 can mimic the stimulatory effect of the natural ligand on phosphoinositide turnover (Griffin and Hawthorne, 1978; Fisher and Agranoff, 198 1; Kendall and Nahorski, 1984) . Depolarizing concentrations of Kf can elicit an increased inositol lipid breakdown in sympathetic ganglia and brain slices (Bone and Michell, 1985; Kendall and Nahorski, 19854 , and the Ca2+ channel activator BAY-K-8644 can mimic K+ depolarization (Kendall and Nahorski, 198%) . Although some of these effects may be indirect, e.g., via release of a neuropeptide, as suggested by Bone and Michell(1983, a direct effect of elevated intracellular [Ca"] on the inositide phosphodiesterase seems possible. Whether this phosphodiesterase is actually regulated by physiologically relevant changes in intracellular [Ca2'] seems less certain. Nevertheless, this possibility should not be excluded, because in both permeabilized bovine chromaffin cells and GH3 pituitary cells, PIP2 phosphodiesterase activity is increased in the presence of Ca2+ concentrations that are well within physiological limits (Martinet al., 1986; Eberhard and Holz, 1987) .
That it took so many years to recognize that stimulated phospholipid breakdown occurs at the level of PIP2 rather than PI (Fig. 2) can be attributed to several technical factors. For example, conventional lipid extraction does not extract PIP or PIP,. But even with the requisite acidified lipid extraction procedure, techniques that permit PIP and PIP2 to migrate and separate on TLC plates were developed only in the past few years (Jolles et al., 1981 ; for review, see Hajra et al., 1987) . Furthermore, the 4' and 5' positions of the polyphosphoinositides are rapidly labeled with 32Pi via the phosphoinositide kinase and phosphatases, and these steps are insensitive to ligand stimulation. Label in these two positions tends to equilibrate quickly with that in the y phosphate of ATP and, thus, to reflect more the amounts of PIP and PIP2 in a preparation than their stimulated labeling. Because of this, possible stimulated labeling in the D-1 phosphodiester position is obscured.
In all three of the inositol lipids, there is an enrichment in stearate at sn-1 and of arachidonate at sn-2. One might then expect that stearoyl arachidonoyl DG would be selectively efficacious in activating PK-C. This has not yet proven to be the case. In fact, there is very little demonstrated fatty acid specificity in DG effects on PK-C (Mori et al., 1982) . The synthetic DG 1-oleoyl-2-acetyl-sn-glycerol has been particularly useful experimentally because of its high solubility. Phorbol esters have proven to be excellent tools for studying activation of PK-C, because they can be taken up by cells and bind to the DG site. Increased intracellular Ca2' levels can activate phospholipase A2, so that phosphoinositide-related activation may release free fatty acids. Because arachidonate is a precursor of the prostanoids, there may be a link between stimulated inositide turnover and stimulation of prostanoid synthesis. It should be pointed out, however, that if the labeling cycle is to be preserved, DG must survive. This appears to be the case for nerve ending preparations, because following carbamoylcholine stimulation, 74-85% of 32P-labeled PA and PI produced could be accounted for by the tetraenoic species, as detected by argentation TLC (Van Rooijen et al., 1985) . Nevertheless, deacylation-reacylation reactions could exchange arachidonate for other fatty acids in DG or in any one of a number of intermediates of the cycle depicted in Fig. 2b .
Much work on stimulated inositol lipid turnover in the nervous system has used the muscarinic receptor as its model. As described below, it has been shown in hippocampus that the stimulated turnover is related to a postsynaptic neuronal site. Figure 3 attempts to integrate the presently known reactions in stimulated phosphoinositide turnover within the typical conceptualization of a muscarinic synapse.
The inositol phosphates
The brain contains several inositol phosphates (Agranoff, 1978) , as well as high levels of free myoinositol relative to other tissues (Sherman et al., 1968) . The inositol phosphates D-myo-inositol 1 -phosphate (D-1-IPl), D-myo-inositol 1 ,4-bisphosphate (D-1,4-IP2), and ~-1,4,5-IP~ (see Fig. 4 ) are the products of phosphodiesteratic cleavage of PI, PIP, and PIP2, respectively. The three inositol phosphates may also exist as 1,2 cyclic derivatives, in which a five-membered phosphodiesteratic ring is formed between the D-1 equatorial and the D-2 axial positions. D-1,2 (cyclic) myo-inositol phosphate [(cl ,2)-IPl] is the best characterized of the cyclic inositol phosphates (Pizer and Ballou, 1959) . It is produced in roughly equal amounts with D-l-IPI on phosphodiesteratic cleavage of PI (Dawson et al., 197 1) . It is tempting to speculate that the cyclic derivatives are initial products of the phosphoinositide phosphodiesterase and are eventually cleaved at the 2 position by a cyclic IP phosphodiesterase. Cyclic IP3 may be degraded to cIP2, thence to cIPl, and finally to IPl . The argument is given support by the recent isolation from placenta of a phosphodiesterase that acts on cIPl but that is not active against cyclic derivatives of IP2 or IP3 (Ross and Majerus, 1986 ). The brain also contains D-~-IP, (the same compound as L-1-IPJ, derived from the reductive cy- (1) is either hydrolyzed by acetylcholinesterase (2) followed by uptake of choline (Ch) (3) or, alternatively, interacts with the muscarinic receptor on the postsynaptic cell surface (4). The activated receptor-ligand complex, possibly acting through a G-protein (5), leads to phosphodiesteratic cleavage (6) of PIPp. A product, DG, activates PK-C (7), which then catalyzes protein (X) phosphorylation in the presence of Ca", leading to physiological cell responses by as yet unestablished mechanisms. The other product of PIPp cleavage is 1,4,5-&, and, very likely, its 1,2 cyclic derivative (see text). 1,4,5-IP3 binds to the endoplasmic reticulum (ER) resulting in increased cytosolic Cap+ (8), thus activating Ca2'-dependent protein kinases that phosphorylate other classes of protein substrates (Y) . The action of 1,4,5-IP3 can be terminated by a membrane-bound 5'-phosphohydrolase (9), yielding 1 ,4-IP2, which has no Ca2+-mobilizing action; 1 ,4,5-IP3 may alternatively be phosphorylated to IP4 via a 3'-kinase (10) present in brain cytosol. The fate of IP4 is not known, but it is tempting to speculate that there exist alternatives: The 5'-phosphohydrolase is expected to degrade IP4 to the known inactive isomer 1,3,4-IP3 ( l l ) , whereas a hypothetical 3'-phosphohydrolase (1 2) would reconvert the IP, to 1 ,4,5-IP3. DG is inactivated by its conversion, via DG kinase (13), to PA, thus initiating recycling to PIP, via CDP-DG, PI, and PIP. PIP kinase (14) and PIPp phosphatase (15) together constitute an enchange system that rapidly equilibrates the 5-phosphate of PIP2 with the y phosphate of ATP. Also shown is the muscarinic receptor that is negatively coupled to adenylate cyclase (16). CAMP, cyclic AMP; R, receptor. c D p c l < + clization of glucose 6-phosphate (Eisenberg, 1967) . The brain, like testis, may be a net producer of inositol. The same phosphatase cleaves both D-1-and D-3-IP1 and is inhibited by Li+ (Hallcher and Sherman, 1980) . This observation was used to advantage by Berridge et al. (1982) in devising an assay for stimulated inositol lipid turnover with [3H]inositol. The presence of Li+ permits the accumulation of labeled IP, , which otherwise would be degraded by the phosphatase. Of the various inositol phosphates, 1 ,4,5-IP3 has been of most interest because of its demonstrated ability to mobilize Ca" from intracellular stores in the endoplasmic reticulum (Streb et al., 1983; Burgess et al., 1984; Thomas et al., 1984; Prentki et al., 1984) , probably through its interaction with specific receptor sites (Baukul et al., 1985; Spat et al., 1986a,b) . The effect of IP3 on endoplasmic reticulum may be mediated by a guanine nucleotide regulatory mechanism (Dawson, 1985; Gill et al., 1986) . Because the highly charged molecule cannot readily enter cells, demonstration of its effects has required permeabilization of cells by various means or, in the case of large cells such as oocytes (Oron et al., 1985) , direct injection of IP3. Irvine et al. ( 1984) found the presence of a form of IP3 that is inactive in Ca2+ mobilization and. in a series of ingenious experiments, established its structure as the 1,3,4 isomer. It now appears that the source of the 1,3,4 isomer is I ,4,5-IP3: 1,4,5-IP3 is phosphorylated by a specific kinase present in brain extracts to form D-myo-inositol 1,3,4,5-tetrakisphosphate (1,3,4,5-IP4) (Batty et al., 1985; Irvine et al., 1986) . It can then be selectively dephosphorylated by the specific 5'-phosphohydrolase in brain (Erneaux et al., 1986) to yield the 1,3,4 isomer. What, then, is the significance of these reactions? At present, it appears that IP4 does not mobilize Ca2+ from intracellular stores, although it has been postulated that it may actually gate Ca2+ across the plasma membrane (Hansen et al., 1986) . One may speculate that, in addition to the known 5'-phosphohydrolase, thought to be the "off' enzyme of the Ca2+ mobilization signal of 1,4,5-IP3 (Connolly et al., 1985) , there may also be a 3'-phosphohydrolase. If this proves to be the case, then IP4 might be preferentially converted back to the 1,4,5 isomer via the action of the putative 3'-phosphohydrolase, rather than to the inactive isomer 1 ,3,4-IP3, even though this does not appear to be the case in the parotid gland (Hawkins et al., 1986) . These possibilities are shown in This isomer is present in avian erythrocytes in relatively high amounts, but may possibly be present in other tissues.
of IP3 and IP4 (Connolly et al., 1986) . It is of interest, in this regard, that when (c1,2)4,5-IP3 is injected into the photoreceptor cells of the horseshoe crab, Limulus, a membrane conductance change is seen similar to that induced by light, with a potency five times that seen with the noncyclic derivative, 1 ,4,5-IP3 (Wilson et al., 1985~) . One may wonder why it is IP3, rather than IP2 or IP, , that is recognized by the cell as the signal for Caz+ mobilization. In this regard, it has been hypothesized (Holmsen et al., 1985) that the relative amounts of membrane PI, PIP, and PIP2 reflect the energy charge of the cell, such that PIPz content is reduced at low energy levels. Thus, we may speculate further that a cell is protected from increasing its intracellular Caz+ content when its ATP content is low: When membrane PIPz content is reduced, IP3 production is also reduced. This safety device would then protect the cell from self-destruction, because increasing intracellular Ca" levels under conditions when this cation cannot be quickly removed (i.e., low ATP levels) would lead to activation of Caz+-mediated proteases, of phospholipase Az, etc., which, if sustained, would result in irreparable cellular damage.
INTRACELLULAR MESSENGER GENERATION AND BIOCHEMICAL SEQUELAE
Calcium signaling It is perhaps a reflection of the daunting complexity of the CNS that direct evidence linking PIPz breakdown and the generation of Ca2+ signals has, thus far, been restricted to simple neurotumor cells, such as the pheochromocytoma PC-12, neuroblastoma N1 El 15, neuroblastoma-glioma hybrid NG-108-15, and astrocytoma 132 IN1 cells. In each of these cell types, addition of agonists known to promote the breakdown of inositol lipids also elicits a demonstrable increase in intracellular [Ca"], even though the intensity and duration of the Ca2+ signal differs considerably, depending on cell type and ligand in question (Masterset al., 1984; Yano et al., 1984; Orellana et al., 1985; Vicentini et al., 1985; Snider et al., 1986) . The possible linkage of PIP2 breakdown and Ca2+ signals has also been examined in bovine chromaffin cells. Activation of muscarinic receptors in these cells results in an increased turnover of inositol lipids (Fisher et al., 1981b; Mohd. Adnan and Hawthorne, 1981) , but only a modest increase in intracellular [Ca2+], from 100 to 150 nM (Kao and Schneider, 1985) , which is apparently insufficient to elicit an increase in catecholamine release (Fisher et al., 198 1 b; Cheek and Burgoyne, 1985) . Because IP3 addition to permeabilized chromaffin cells results in the mobilization of intracellular Ca2+, the failure of muscarinic acetylcho- line (ACh) receptor (mAChR) activation to initiate catecholamine release clearly does not result from the absence of IP3 "receptors" on intracellular membranes (Stoehr et al., 1986) . The situation is further complicated by the fact that distinct species differences exist for the biochemical and physiological consequences of mAChR activation in chromaffin cells. Thus, in the guinea pig, mAChR activation results in catecholamine release (Role and Perlman, 1983) , as well as an enhanced turnover of inositol lipids (Figueiredo et al., 1986) . One implication from this finding is that in those species, e.g., rat or guinea pig, in which muscarinic receptor activation results in catecholamine release, more IP3 is produced or less is degraded than in the bovine cell. However, because addition of phorbol esters such as 4P-phorbol 12-myristate 13-acetate (PMA) to guinea pig cells can mimic the effect of muscarinic stimulation on catecholamine release both temporally and quantitatively (Figueiredo et al., 1986) , the further possibility must be considered that activation of PK-C is of primary relevance for initiation of exocytotic events.
Production of DG: role in protein phosphorylation
It is now well established that DG released from the breakdown of PIP2 may serve to activate PK-C, and that as a result, its affinity for Ca2+ is lowered, such that in the presence of phosphatidylserine, concentrations of Ca2+ as low as 0.1 pM fully activate the enzyme (Nishizuka, 1984; Hirasawa and Nishizuka, 1985) . What is much less clear is the identity of specific substrate proteins for PK-c. Gispen and colleagues have proposed that a membrane protein designated BSO may be one such substrate (Van Dongen et al., 1985) and that the phosphorylated form inhibits PIP kinase. Addition of corticotropin ( 1 -24)tetracosapeptide (ACTH) inhibits BS0 phosphorylation, with the net effect that addition of the neuropeptide leads to an increase in PIP2 synthesis. This result suggests that DG, acting through PK-C, is a regulator of PIP2 steady-state concentrations in neural membranes. Although in this case DG ultimately reduces PIP2 concentrations, it may also inhibit receptor-mediated breakdown of PIP2. Labarca et al. (1984) demonstrated that addition of PMA at nanomolar concentrations results in an inhibition of carbachol-induced release of inositol phosphates from hippocampal slices, whereas the basal turnover of the lipid pool is unaffected. A similar result was obtained by Kanba et al. (1986) with NlE-115 cells. In cultured astrocytoma cells, phorbol esters block both the carbamoylcholine-stimulated breakdown of inositol lipids and the resulting Ca2+ signal (Orellana et al., 1985) . The mechanism of this inhibition remains unknown for most cells, but in the DDTl MF-2 smooth muscle cell line, PMA addition results in phosphorylation of the Q! ,-adrenergic receptor itself (Leeb-Lundberg et al., 1985) . That phorbol esters are capable of modulating neuronal physiology is supported by the recent demonstration that addition of PMA can alter ionic conductance in hippocampal pyramidal cells (Baraban et al., 1985) and in Aplysia bag cells (De Riemer et al., 1985) . However, application of phorbol esters to hippocampal pyramidal cells can mimic some, but not all, of the electrophysiological responses associated with activation by a receptor agonist (Malenka et al., 1986) .
Evidence that both DG and IP, may play a pivotal role in neuronal signaling was recently obtained by Higashida and Brown (1986) using the NG108-15 neuroblastoma-glioma hybrid cell line. In these cells, addition of bradykinin results in both a hyperpolarization and a depolarization of the membrane. The hyperpolarization response is mimicked by intracellular injection of either Ca2+ or IP, , whereas depolarization can be elicited by addition of phorbol esters or 1 -oleoyl-2-acetylglycerol. These results suggest that in NG 108-15 cells, the initial breakdown of PIP2 results in message formation that first inhibits and then accelerates neuronal discharge, and that in this way, neuronal signaling is modified.
PHARMACOLOGICAL CHARACTERISTICS
The availability of novel selective ligands together with the development of more specific assay methods for phosphoinositide turnover has resulted in significant advances in our understanding of receptor coupling to inositol lipid turnover. The number of receptors implicated in inositol lipid turnover in the CNS continues to grow, and in several instances, there is evidence for the involvement of a specific receptor subtype. Furthermore, the relationship between the binding of ligands to the receptor and the ensuing activation of phospholipase C has begun to unfold. At least 1 7 pharmacologically distinct receptor types have been claimed to be coupled to inositol lipid turnover (Table l) , but the amount of evidence supporting the involvement of each receptor in question vanes considerably. They have been subdivided into two groups on the basis of the strength of available supportive evidence. In addition, a third group of receptors is identified for which there is good evidence that they are not linked to activation of phosphoinositide phosphodiesterase.
A. Receptors established to be coupled to phosphoinositide turnover
Muscarinic cholinergic. The initial observations that activation of mAChRs in brain slices resulted in an increase in phosphoinositide turnover has since been amply confirmed in a variety of neural preparations, including nerve ending preparations, brain minces, and primary cultures of neurons and glia, as well as transformed cells of neural origin, such as neuroblastoma and astrocytoma (for review, see Fisher and Agranoff, 1985) . Within the CNS, there exists a strong correlation between the density of mAChRs, as determined by radioligand binding techniques, and Bemdge et al. (1982) , Brown et al. (1984) , Fisher et al. (1984) , Gonzales and Crews (1984) , Fisher and Bartus (1985) , Gil and Wolfe (1989 , Jacobson et al. (1989 , Lazareno et al. (1983 , Eva and Costa (1986 ),Heacocketal. (1987 Schoepp et al. (1984) , Johnson and Minneman (1985) , Kendall et al. (1989, Minneman and Johnson (1984) -Bush (1984 -Bush ( , 1985 .
Choroid plexus Glutamatergic ? Brain slices Nicoletti et al. (1985 Nicoletti et al. ( , 1986a Enjalbert et al. (1986) CCK, cholecystokinin; NGF, nerve growth factor; VIP, vasoactive intestinal peptide. Simmonds and Strange (1985) Receptors listed in the B category are those that when activated elicit a minimal increase in phosphoinositide turnover in tissue preparations from the CNS, even though much larger stimulations of inositol lipid turnover are, on occasion, observed in neurotumor cells or in other neural-related tissues.
the magnitude of stimulated inositol lipid turnover (Downes, 1982 (Downes, , 1983 . Increases in inositol lipid turnover in response to cholinergic agonists is primarily, if not entirely, due to the activation of mAChRs. In those instances where a nicotinic cholinergic involvement has been implicated, e.g., superior cervical ganglion (Briggs et al., 1985) or the bovine chromaffin cell (Eberhard and Holz, 1987) , this effect may be due to indirect effects of the nicotinic agonist-such as the release of a secondary neurotransmitter or activation of phospholipase C resulting from the elevation of cytosolic Ca2+ concentration. Further support for the sole direct involvement of mAChRs is derived from experiments using antagonists. Addition of muscarinic antagonists such as scopolamine or atropine inhibits the phosphoinositide response, whereas nicotinic antagonists such as d-tubocurarine are largely without effect. Muscarinic agonists differ considerably in their ability to enhance phosphoinositide turnover in brain. In the cerebral cortex, a group of agonists, including ACh, carbamoylcholine, and oxotremorine-M, is more effective than several others, including pilocarpine, bethanechol, and oxotremorine (Fisher et al., 1983 (Fisher et al., , 1984 Gonzales and Crews, 1984; Jacobson et al., 1985) . The former group of agonists have been termed "group A" agonists, and the latter, "group B." Not only are group B agonists less effective when added alone, but when present in incubations containing group A agonists, they block the effect of the more efficacious group A agonists and are, therefore, considered to be partial agonists. It is of interest to note that this pattern of agonist efficacy is very different from that for another biochemical consequence of mAChR activation, inhibition of adenylate cyclase (Olianas et al., 1983; Brown and Brown, 1984) , but is very similar to that described for mAChR stimulation of guanylate cyclase (McKinney et al., 1985) . The ability of muscarinic agonists to enhance inositol lipid turnover is highly correlated with the binding characteristics of the agonist. In cerebral cortex, group A agonists readily discriminate at least two affinity forms (high and low) of the mAChR, whereas group B agonists bind predominantly to a single affinity form (Fisher, 1986 ). This observation indicates that muscarinic agonists differ in their ability to produce an optimal conformational change in the mAChR and that this is related to the subsequent activation of the phosphodiesterase. There are also indications that there are regional, developmental, and tissue differences in the way mAChRs are coupled to inositol lipid turnover. In the guinea pig neostriatum (Fisher and Bartus, 1985) , in neonatal rat cerebral cortex (Heacock et al., 1987) , and in the human neuroblastoma SK-N-SH cell line (Fisher and Snider, 1986) , group A agonists are more potent stimulators of phosphoinositide hydrolysis than in the adult cortex, whereas, conversely, several group B agonists are more effective.
In both the CNS and nonneural tissues, the existence of MI and M2 mAChR subtypes has been proposed on the basis of the presumed selectivity of the antagonist pirenzepine (Watson et al., 1985) . A suggestion that the phosphoinositide response in the CNS is a function of activation of the MI subtype alone appears unwarranted (Vickroy et al., 1984) ; both MI (pirenzepine-sensitive) and M2 (pirenzepine-insensitive) characteristics are observed for stimulated lipid turnover. Thus, whereas pirenzepine is a potent inhibitor of the phosphoinositide response in the cerebral cortex, hippocampus, and AtT-20/D 16-6 pituitary cells (Ki, -10-20 nM) (Gonzales and Crews, 1984; Fisher and Bartus, 1985; Gil and Wolfe, 1985; Smith and Yamamura, 1985; Akiyamaet al., 1986) , it isconsiderably less potent in the neostriatum, astrocytoma cell, and brainstem (Ki, 100-300 nM) Fisher and Bartus, 1985; Lazareno et al., 1985) . Both putative MI and M2 mAChR subtypes may be coupled to phosphoinositide turnover in neural tissues.
Adrenergic. There is good evidence that the al-adrenergic receptor subtype is specifically coupled to stimulated inositol lipid turnover. Phosphoinositide hydrolysis elicited by norepinephrine can be blocked by the a l-adrenergic blockers prazosin or phentolamine, but not by yohimbine, an a2-adrenergic blocker, or by propranolol, a ,f3-adrenergic antagonist Minneman and Johnson, 1984; Shoepp et al., 1984; . As is observed for the muscarinic response, adrenergic agonists differ in their ability to enhance inositol lipid turnover. Methoxamine and phenylephrine are partial agonists, whereas other known al-selective agonists, such as oxymetazoline, and ephedrine have no measurable effect (Minneman and Johnson, 1984) . The aI-adrenergic response is detectable in most, if not all, brain regions, but the magnitude of the effect does not correlate well with the density of al-adrenergic receptors, a result suggesting that receptor density alone is not the sole determinant of response magnitude (Johnson and Minneman, 1985) . An explanation may lie in the recent demonstration of a]-receptor subtypes that are differentially sensitive to the effect of the alkylating agent chlorethylclonidine. One of the a1 subtypes appears to be coupled to phosphoinositide turnover, whereas the other is linked to activation of adenylate cyclase (Minneman and Johnson, 1986) .
Histaminergic. In the CNS and neuroblastoma and astrocytoma cells, the phosphoinositide response appears to be mediated through an HI receptor, because the stimulatory effect of histamine can be blocked by inclusion of pyrilamine, an HI antagonist, whereas the H2 antagonist cimetidine is ineffective (Subramanian et al., 1980) . Furthermore, the magnitude of histamine-stimulated inositide turnover mirrors that of the density of HI receptors (Daum et al., 1983 (Daum et al., , 1984 . Regional differences in coupling characteristics (ECSo values and partial agonist efficacies) of H1 receptors linked to phosphoinositide turnover have recently been observed (Carswell and Young, 1986) .
Serotonergic. In the cerebral cortex, 5-HT2 receptors appear to be coupled to inositide turnover, because addition of the potent 5-HT2 antagonist ketanserin blocks the response (Conn and Sanders-Bush, 1984 Kendall andNahorski, 1985b) . The situation is less clear in all other brain regions examined, because there appears to be little correlation between the density of [3H]ketanserin binding sites and magnitude of the phosphoinositide response. Furthermore, ketanserin does not readily antagonize the response in these brain regions. Recently, a new serotonin subtype, 5-HT1,, has been implicated in stimulation of phosphoinositide turnover elicited by addition of serotonin to the choroid plexus . This receptor subtype differs from the 5-HT2 receptor in its greater affinity (10-fold) for serotonin and its relative insensitivity to ketanserin and spiperone. It would appear, then, that there are at least two Shydroxytryptamine (5-HT) subtypes coupled to phosphoinositide turnover.
Glutarnatergic. Nicoletti et al. (1985 Nicoletti et al. ( , 1986a have demonstrated that addition of glutamate or ibotenate, its rigid structural analog, elicits a large increase in the accumulation of inositol phosphates. This effect is most evident in neonatal tissue and declines with maturity. In hippocampus, quisqualate is a partial agonist, whereas N-methyl-D-aspartate (NMDA), kainate, quinolinate, and N-acetylaspartylglutamate are inactive. The pharmacological characteristics of ibotenate-stimulated phosphoinositide turnover are not consistent with three glutamate receptor subtypes characterized primarily electrophysiologically ("quisqualate," "NMDA," or "kainate"), but rather share some similarities with the putative DL-2-amino-4-phosphonobutyric acid (APB) receptor, as determined from recent electrophysiological and radioligand binding studies. APB antagonizes ibotenate stimulation of inositol lipid turnover. However, although DL-2-amino-5-phosphonovalerate (APV) does not antagonize ibotenate-mediated inositol lipid turnover, it displaces [3H]APB, an observation indicating additional complexity. Using cultured striatal neurons, Sladeczek et al. (1985) have also observed that addition of glutamate enhanced the release of inositol phosphate. However, the glutamate agonists' profile is different from that observed in hippocampus: Whereas glutamate and quisqualate are full agonists in the striatum, NMDA and kainate are partial agonists. APV inhibited the reaction to NMDA, but not to glutamate, kainate, or quisqualate. These results suggest that a quisqualate or NMDA receptor subtype is involved, although it is probable that the activation of several glutamate receptor subtypes can enhance inositol lipid turnover. As a result of these findings, it is now generally accepted that some glutamate receptor subtypes, long thought to couple directly to plasma membrane ionophores, may instead operate through the generation of a second messenger signal.
B. Receptors purported to be coupled to phosphoinositide turnover
Several neuropeptide receptors may be coupled to inositol lipid turnover in brain, but a more definite statement must await independent confirmation of what are, at best, marginal effects on labeled inositol phosphate release. In this category are included substance K, neuromedin (Hunter et al., 1985) , neurotensin (Goedert et al., 1984) , and cholecystokinin receptors (Downes, 1983) . The evidence suggesting a linkage between substance P receptors and inositol lipid turnover is somewhat more convincing. Mantyh et al. ( 1984) have demonstrated a correlation between the receptor density of substance P receptors, as determined autoradiographically, and the magnitude of inositol phosphate release. In the hypothalamus, the substance P-P receptor subtype has been implicated in inositol lipid turnover on the basis of agonist studies (Watson and Downes, 1983) . Addition of vasopressin to hippocampal slices elicits only a small increase in inositol phosphate release (1 50% ofcontrol) (Stephens and Logan, 1986) , whereas its effect is much greater in the superior cervical ganglion , even though vasopressin may not be a natural ligand for this receptor (Hanley et al., 1984) . In transformed cells of neural origin, such as neuroblastoma N1E-I 15, neuroblastoma-glioma hybrid, or GH3 pituitary cells, there is strong evidence favoring linkage of neurotensin, bradykinin, and thyrotropin-releasing hormone (TRH) receptors to stimulated inositol lipid turnover (Martin, 1983; Yano et al., 1984; .
C. Receptors not directly coupled to stimulated phosphoinositide turnover
The list of receptors that have been studied in which no evidence could be found for linked phosphoinositide turnover include several that are either positively or negatively coupled to adenylate cyclase, e.g., HZhistaminergic, 5-HT ,-serotonergic, P-adrenergic, and a*-adrenergic, in addition to the nicotinic cholinergic and GABAergic receptors.
D. Receptor occupancy requirements for phosphoinositide hydrolysis
A close relationship exists in the CNS between occupancy of the receptor by the agonist and the degree of stimulation of inositol lipid turnover. Two lines of evidence support this statement. First, the abilities of either muscarinic or adrenergic ligands to stimulate the release of labeled inositol phosphates correlates well with their abilities to displace radiolabeled antagonists from specific membrane binding sites (Fisher et al., 1983 (Fisher et al., , 1984 Minneman and Johnson, 1984) . Second, the loss of receptor number either in vivo following neurotoxin treatment (Fisher et al., 1981~) or in vitro following irreversible inactivation of a proportion of the muscarink, a,-adrenergic, 5-HT2-serotonergic, or H,-histaminergic receptors results in a comparable loss of receptor-stimulated phosphoinositide turnover (Johnson and Minneman, 1985; Kendall and Nahorski, 1985b; Claro et al., 1986; Fisher and Snider, 1986) . Some indication that this normal tight coupling between receptor occupancy and response might be capable of adaptive change was obtained by Kendall et al. (1 985) . Following central noradrenergic denervation, the ECso for norepinephrine in the hippocampus was significantly reduced, and the partial agonist phenylephrine became more efficacious. Moreover, al-adrenergic receptor alkylation with phenoxybenzamine resulted in a greater loss of receptor number than of the inositide response. These results can be interpreted as indicative of the development of a small receptor reserve for the phosphoinositide response following denervation. The observation that 1 0-fold lower concentrations of norepinephrine (but not of carbamoylcholine) are required to elicit a half-maximal increase in IP3 accumulation in denervated iris smooth muscle is also consistent with the development of a "receptor reserve" for the a,-adrenergic receptor (Akhtar and Abdel-Latif, 1986 ).
E. Signal transduction
In nonneural tissues, there presently exists a significant amount of evidence to support the involvement of a guanine nucleotide binding (G) protein in the transduction process (Joseph, 1985; Litosch et al., 1985) , even though the identity of the G-proteins remains to be determined. There is little direct evidence to invoke such a mechanism for neural receptors at present. However, the inositide phosphodiesterase in brain has been shown to be stimulated by GTP or its nonhydrolyzable analogs (Gonzales and Crews, 1985) . Outside the CNS, addition of GTPyS to permeabilized chromaffin cells results in a release of IP3, IP2, and IP, (Eberhard and Holz, 1987) , whereas GTP potentiates the effect of TRH in cell-free preparations from GH3 pituitary cells . In human astrocytoma cells, a strong correlation exists between the ability of muscarinic agonists to enhance phosphoinositide turnover and their propensity to induce the appearance of a high-affinity GTP-sensitive form of the mAChR (Evans et al., 1985) . These results, taken collectively, suggest a role for G-proteins in signal transduction at inositide-linked receptors in the CNS. A recent theory proposed by Rodbell (1 985) envisages that, on receptor activation, the a subunit of the G-protein is released from the membrane and that subsequent modifications occur to yield new forms of the protein with differing functions. If correct, the implication of this theory is that these "programmable messengers" are, in fact, the true second messengers of hormone action and that IP3 and DG comprise tertiary signals.
F. Desensitization
A characteristic of stimulated inositol lipid turnover is its persistence, so long as the agonist continues to occupy the receptor. In brain slices, for example, the continued release of inositol phosphates is observed for up to I20 min following addition of carbamoylcholine (Fisher and Bartus, 1985) . Masters et al. ( 1984) have demonstrated that in human astrocytoma cells, preexposure of the cells to carbamoylcholine results in a loss of stimulated Ca2+ efflux but not of the production of inositol phosphates, a result suggesting that desensitization occurs distal to PIP2 hydrolysis. However, some caution is necessary before this interpretation is universally applied, because in most studies, accumulation of IP, rather than IP3 or its isomers is measured.
Modulation of phosphoinositide turnover by inhibitory receptors
In addition to those receptors that can enhance the breakdown and resynthesis of inositol lipids, there may be a separate class of receptors that regulate the extent of stimulated inositol lipid turnover. For example, in the platelet, agents that elevate the tissue cyclic AMP concentration, such as prostaglandin E and forskolin, inhibit thrombin-mediated PIP2 breakdown, the generation of Ca2+ signals, and subsequent physiological responses (Nishizuka, 1984) . Comparable observations in the CNS are limited and often equivocal. Thus, although forskolin failed to reduce either carbamoylcholine-or norepinephrine-mediated stimulation of inositol lipid turnover in cerebral cortex slices (Hollingsworth and Daly, 1985) , an inhibitory effect was observed by Nicchitta and Williamson (1986) , using nerve ending preparations. Similarly, although it has been claimed that administration of excitatory amino acids (kainic acid, NMDA, or DL-homocysteate) exerts an inhibitory effect on phosphoinositide turnover elicited by carbamoylcholine, histamine, or K+ depolarization, and not by norepinephrine (Baudry et al., 1986) , an inhibition of norepinephrinelinked, and not of carbamoylcholine-linked, stimulation was observed by Nicoletti et al. (1986b) .
In the retina, light stimulation elicits an increased phosphoinositide turnover that is mediated in part by release of ACh (Anderson and Hollyfield, 198 I ; Anderson et al., 1983; Schmidt, 1983a,b) and can be blocked by administration of glycine (Anderson and Hollyfield, 1984) . The inhibitory effect of glycine is, in turn, reversed by preincubation with strychnine. In the anterior pituitary, activation of D2-dopaminergic receptors results in both an inhibition of adenylate cyclase and a 40% reduction in the stimulated turnover of inositol lipids elicited by TRH or its analog DN 1417 (Simmonds and Strange, 1985) . For the same tissue, Enjalbert et al. (1986) have observed that D2-receptor activation in lactotrophs results in a 50% inhibition of angiotensin 11-stimulated inositol phosphate release. To date, the D2 receptor represents the best-documented example of a receptor-mediated inhibition of inositol phosphate release.
Cellular and synaptic localization of receptors coupled to phosphoinositide turnover Until recently, a role for glia in stimulated phospholipid turnover in the CNS has largely been ignored, despite earlier indications that inositide turnover in both neuronal and glial cell-enriched fractions could be enhanced by addition of neurotransmitters (Woelk et al., 1974; Abdel-Latif et al., 1974) and the fact that the number of glial cells may exceed that of neurons by severalfold in the adult mammalian CNS. The possible involvement of glia in receptor-mediated phosphoinositide turnover has been examined in primary cultures of cortical astrocytes judged to be at least 85% pure by immunocytochemical criteria (Pearce et al., 1985) . In these cultures, addition of muscarinic cholinergic and al-adrenergic ligands st;mulated the release of inositol phosphates, and in terms of agonist affinities and Ca2+ sensitivity, the characteristics of the glial response were very similar to those observed previously for brain slices. However, using primary cultures of both neurons and glia, Gonzales et al. (1985) concluded that the phosphoinositide response is primarily neuronal. Nevertheless, the demonstration of functionally coupled muscarinic receptors on both neuroblastoma (Cohen et al., 1983) and astrocytoma (Masters et al., 1984) cells indicates that glial elements may also play a significant role in stimulated inositol lipid turnover in the CNS.
Receptors are found at both presynaptic and postsynaptic sites, but most of the limited information presently available points to a postsynaptic localization for receptor-enhanced inositol lipid turnover. Early studies on the superior cervical ganglion indicated that much of the increased [3H]inositol incorporation into inositol lipids that occurs after ACh addition was localized autoradiographically to the cell body (Hokin, 1965) . Removal of presynaptic elements failed to reduce appreciably stimulation of lipid labeling elicited by addition of either ACh or nerve growth factor, a result indicating a postsynaptic site for both receptors (Hokin, 1966; Lakshamanan, 1978 Lakshamanan, , 1979 . More recent studies on the hippocampus support this conclusion. Lesion of the adrenergic input by means of microinjection of 6-hydroxydopamine, systemic treatment with the noradrenergic neurotoxin DSP4, or surgical lesion of the medial forebrain bundle did not reduce the magnitude of aladrenergic stimulated inositol phosphate release Fowler et al., 1986) . Surgical lesion of the guinea pig fornix-fimbria also failed to reduce the muscarinic stimulation of inositol lipid turnover, even though activity of the presynaptic marker enzyme choline acetyltransferase was reduced by 80% (Fisher et al., 1980) . In contrast, lesion of postsynaptic structures with the neurotoxin ibotenate resulted in a substantial loss of both muscarinic receptor number and stimulated PA and PI turnover (Fisher et al., 198 la) . Kemp and Downes (1986) also concluded that stimulated phosphoinositide turnover elicited by al-adrenergic agonists in the lateral geniculate nucleus is postsynaptic in location, because lesion of interneurons and cell bodies of afferent neurons with kainic acid reduced the magnitude of phosphoinositide hydrolysis.
Despite the prevailing evidence, the possibility is not excluded that there are also presynaptic receptors coupled to phosphoinositide turnover.
POSSIBLE RELEVANCE OF PHOSPHOINOSITIDE TURNOVER TO NEURAL FUNCTION

Neuronal plasticity
Rapidly axonally transported proteins associated with neuronal growth and regeneration have been identified (Skene and Willard, 1981; Heacock and Agranoff, 1982; Benowitz and Lewis, 1983; Katz et al., 1985) . More recently, it has been demonstrated that one of these proteins, designated growth-associated protein 43 (GAP43), is characteristic of growth cones (Meiri et al., 1986) . It is identical with the BS0 protein found in plasma membrane and shown to be phosphorylated by PK-C (Meiri et al., 1986) . Because the phosphorylated form of BSo inhibits conversion of PIP to PIP2, this may constitute a regulatory mechanism (Van Dongen et al., 1985) of relevance to brain function. There are other instances of interaction between IP3 turnover and PK-C. For example, the 5'-phosphohydrolase in platelets has been postulated to be phosphorylated by PK-C, thus activating it (Connolly and Majerus, 1986; Molina y Vedia and Lapetina, 1986) . GAP43 phosphorylation has also been implicated in a behavioral memory model, long-term potentiation in the rat hippocampus (Nelson and Routtenberg, 1985) .
A major question in understanding the biochemical basis of memory formation is how information expressed in transduction processes associated with synaptic transmission can eventually lead to changes in macromolecular synthesis that can mediate long-term behavioral changes (Agranoff, 198 1) . A possible mechanism is provided by the phosphoinositide second messengers, which in nonneural systems have been shown to lead to permanent commitment to growth, via oncogenes. By analogy, in neurons, a positive feedback loop may be induced via an increased intracellular Ca2' content, which converts a behaviorally induced transient synaptic response to a permanent one (Bemdge, 1986; Goelet et al., 1986) .
Nerve-impulse conduction: role of inositide turnover in diabetic neuropathy
The known localization of PIP and PIP2 in plasma membranes and the propensity of these lipids to bind divalent cations have led to the speculation that PIP-PIP2 interconversions might regulate the amount of Ca2' bound to specific membrane sites and, thereby, influence the operation of Na+ and Kf channels (Hawthorne and Kai, 1969) . However, it is unclear how responsive the polyphosphoinositides are to changes in nerve conduction, and conflicting results have been obtained from a variety of neural preparations subjected to electrical stimulation (Goswami and Gould, 1985 ; for review, see Fisher and Agranoff, 1985) . Furthermore, Mg2+, a cation present in the cytosol in much greater concentrations than Ca2+, also binds to the polyphosphoinositides. Indirect evidence for a role of the polyphosphoinositides in nerve conduction has come from recent studies on sciatic nerves of rats made diabetic by streptozotocin, a treatment that leads to a diabetic neuropathy. Altered PI turnover has been previously implicated in diabetes Whiting et al., 1977) , and recently Eichberg and colleagues (Bell et al., 1982; BertiMattera et al., 1985) have demonstrated a substantial increase in "Pi incorporation into PIP2 in diabetic animals. The changes could be reversed by insulin administration. A reduction in Na+,K+-ATPase activity has been observed for diabetic sciatic nerve Lattimer, 1983, 1985) ; furthermore, the ouabainsensitive component of respiration, which is reduced in this tissue, can be normalized by in vitro administration of PMA (Greene and Lattimer, 1986) . Collectively, these results suggest a link among changes in phosphoinositide turnover, axonal conduction, and transmembrane ion gradients in the nerve.
PI as an anchor for membrane proteins
Low and colleagues have provided convincing evidence that certain membrane proteins and enzymes are anchored within the membrane through a covalent linkage to a ring hydroxyl of PI (Low and Finean, 1978; Low and Zilversmit, 1980; Low et al., 1986) . The same group has recently demonstrated that the attachment of Thy-1, a cell-surface glycoprotein, to neural membranes also involves a PI linkage (Low and Kincade, 1985) . A phospholipid tentatively identified as either PIP or PIP2 is also implicated in a covalent linkage to myelin basic protein (Yang et al., 1986) . This observation assumes importance in light of the known high polyphosphoinositide content of myelin and the suggestion that this is the site of a metabolically inactive pool of these lipids (Eichberg and Hauser, 1973) .
Cuatrecasas and colleagues have demonstrated that, in liver, PI may also be linked to a carbohydrate moiety. Following activation of phospholipase C by insulin, it is proposed that two second messengers are formed: in addition to DG, there is an inositol phosphate glycan that regulates cyclic AMP phosphodiesterase . These findings attest further to the diversity of functions that inositol lipids are already known to play in cellular physiology.
IS THERE A LINK BETWEEN PHOSPHOINOSITIDE HYDROLYSIS AND PSYCHIATRIC DISORDERS?
Role of lithium Despite the long-term use of Lit in the treatment of manic depressive disorders, only recently has any hint of the underlying mechanism of its action become apparent. Largely as a result of the studies of Sherman and colleagues Hallcher and Sherman, 1980) , it is now established that administration of therapeutically relevant concentrations of Li+ results in the accumulation of inositol monophosphate in brain and that this is the result of the selective inhibition of inositol 1 -phosphatase (Hallcher and Sherman, 1980) . The net effect of Li+ administration is a decrease in myo-inositol availability, which theoretically could result in a reduction of PI synthesis, especially in view of the relative impermeability of the blood-brain barrier to inositol (Spector and Lorenzo, 1975) . It has been proposed that Li+ may preferentially regulate those Ca2+-mobilizing receptors that are "hyperactive" and thus act as a calcistat (Berridge et al., 1982) . Ofinterest is the recent observation that chronic administration of Li+ results in an increased activity of brain inositol 1 -phosphatase, a mechanism presumably designed to compensate for the inhibitory effect of Li+ (Renshaw et al., 1986) . It should be pointed out that the key regulated step in the cycle is likely to be the resynthesis of PIP2 rather than PI. In this context, it is noteworthy that Downes and Stone (1986) have observed that, in the parotid gland, administration of Lif resulted in an accumulation of CDP-DG (due to inositol depletion) but had no effect on receptor-mediated PIP2 breakdown. Thus, it appears that the agonist-sensitive pool of phosphoinositides is largely spared the effects of Li' . A similar conclusion was reached by Drummond and Raeburn ( 1984) in studies with GH3 pituitary cells. As in parotid gland, GH3 cells preserve their cellular levels of PIP2, even when faced with a large reduction in the cellular content of PI. Despite these observations, it remains possible that a reduction in intracellular inositol content could result in an adverse effect on the steady-state level of PIP2. Simultaneous determination of the chemical mass of inositol, of inositol lipids, and of Li+ content in a defined cell type would do much to elucidate the interrelationship between Li+ and the phosphoinositides. A key development for future studies will be better separation and quantitative estimation of the inositol phosphates. Almost all of the present reports are based on 32P-or [3H]inositollabeled products, which are poorly characterized and without chemical mass measurements.
Receptor regulation
In addition to providing a better insight into the possible physiological function of a large group of CNS receptors, measurement of phosphoinositide turnover also provides a convenient biochemical measure of receptor activity. This is of particular importance when one considers that many psychotherapeutic agents, including antidepressants and neuroleptics, are known from radioligand binding assays to interact with more than one inositide-linked receptor. Inhibition by these agents of in vitro ligand binding to the mAChR and 5-HT2, al-adrenergic, and H I recep-tors has been documented (Peroutka and Snyder, 1980; Richelson and Nelson, 1984a,b) . Although the magnitude of the regulatory effects of these agents on receptor density following chronic administration may be modest, available assay techniques have sufficient precision to detect them. Moreover, there may be instances in which the changes in phosphoinositide turnover are larger than those in receptor density, for example, as is seen in down-regulation of 5-HT2 receptor number and inositide stimulation following iprindole treatment (Kendall and Nahorski, 1985b) . Such studies may well shed light on the longterm regulation of inositide second messenger generation and on adaptive changes in chemical signaling within the CNS.
CONCLUDING REMARKS
The advantage of reviewing an active research area is that such a review will be timely; the disadvantage is that it will soon be outdated. It is our hope this review will first have served a useful function. If one compares the inositide-linked second messenger systems with an earlier neurochemical era-the elucidation of cyclic AMP mechanisms-we might safely predict that much will be learned about the complexities of signal transduction in the brain. Our new knowledge in this area should also lead to the development of useful pharmacological screens for the development of new drugs.
It is noteworthy that our understanding of the phosphoinositides began with the studies of a pioneer neurochemist, Jordi Folch-Pi, who figures centrally in recent historical reviews of the International Society for Neurochemistry (McIlwain, 1985) and the American Society for Neurochemistry (Tower, 1987) .
